These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33313456)

  • 1. Exploring the percentage of COVID-19 cases reported in the community in Canada and associated case fatality ratios.
    Dougherty BP; Smith BA; Carson CA; Ogden NH
    Infect Dis Model; 2021; 6():123-132. PubMed ID: 33313456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional Variability in COVID-19 Case Fatality Rate in Canada, February-December 2020.
    Shim E
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33672804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Surveillance System in Canada: Longitudinal Trend Analysis.
    Post L; Boctor MJ; Issa TZ; Moss CB; Murphy RL; Achenbach CJ; Ison MG; Resnick D; Singh L; White J; Welch SB; Oehmke JF
    JMIR Public Health Surveill; 2021 May; 7(5):e25753. PubMed ID: 33852410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal estimates of case-fatality rate for COVID-19 outbreaks in Canada and the United States.
    Abdollahi E; Champredon D; Langley JM; Galvani AP; Moghadas SM
    CMAJ; 2020 Jun; 192(25):E666-E670. PubMed ID: 32444481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative risks of COVID-19 fatality between the first and second waves of the pandemic in Ontario, Canada.
    Hsu SH; Chang SH; Gross CP; Wang SY
    Int J Infect Dis; 2021 Aug; 109():189-191. PubMed ID: 34216734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Transmission in Alberta, British Columbia, and Ontario, Canada, December 25, 2019, to December 1, 2020.
    Fung IC; Hung YW; Ofori SK; Muniz-Rodriguez K; Lai PY; Chowell G
    Disaster Med Public Health Prep; 2021 Mar; ():1-10. PubMed ID: 33762027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the progression of the COVID-19 pandemic in Canada using testing data and time-dependent reproduction numbers.
    Edjoc R; Atchessi N; Lien A; Smith BA; Gabrani-Juma I; Abalos C; Heisz M
    Can J Public Health; 2020 Dec; 111(6):926-938. PubMed ID: 33090361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe.
    Hauser A; Counotte MJ; Margossian CC; Konstantinoudis G; Low N; Althaus CL; Riou J
    PLoS Med; 2020 Jul; 17(7):e1003189. PubMed ID: 32722715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 pandemic and Construction Industry: insights from Italian data.
    Riccò M
    Acta Biomed; 2022 Jul; 93(3):e2022233. PubMed ID: 35775779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity among health care leaders in Canada: a cross-sectional study of perceived gender and race.
    Sergeant A; Saha S; Lalwani A; Sergeant A; McNair A; Larrazabal E; Yang K; Bogler O; Dhoot A; Werb D; Maghsoudi N; Richardson L; Hawker G; Siddiqi A; Verma A; Razak F
    CMAJ; 2022 Mar; 194(10):E371-E377. PubMed ID: 35288408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 case fatality risk by age and gender in a high testing setting in Latin America: Chile, March-August 2020.
    Undurraga EA; Chowell G; Mizumoto K
    Infect Dis Poverty; 2021 Feb; 10(1):11. PubMed ID: 33531085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity in testing, diagnosis and outcome in SARS-CoV-2 infection across outbreak settings in the Greater Toronto Area, Canada: an observational study.
    Wang L; Ma H; Yiu KCY; Calzavara A; Landsman D; Luong L; Chan AK; Kustra R; Kwong JC; Boily MC; Hwang S; Straus S; Baral SD; Mishra S
    CMAJ Open; 2020; 8(4):E627-E636. PubMed ID: 33037070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 cases reported from long-term residential facilities (care homes) in South Africa: a retrospective cohort study.
    Arendse T; Cowper B; Cohen C; Masha M; Tempia S; Legodu C; Singh S; Ratau T; Geffen L; Heymans A; Coetzer D; Blumberg L; Jassat W
    BMC Public Health; 2022 May; 22(1):1035. PubMed ID: 35606732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring Substance-Related Disorders Using Canadian Administrative Health Databanks: Interprovincial Comparisons of Recorded Diagnostic Rates, Incidence Proportions and Mortality Rate Ratios.
    Huỳnh C; Kisely S; Rochette L; Pelletier É; Morrison KB; Li S; Hopkin G; Smith M; Burchill C; Lin E; Asbridge M; Jutras-Aswad D; Lesage A
    Can J Psychiatry; 2022 Feb; 67(2):117-129. PubMed ID: 34569874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Riding high: seroprevalence of SARS-CoV-2 after 4 pandemic waves in Manitoba, Canada, April 2020-February 2022.
    Duong S; Burtniak J; Gretchen A; Mai A; Klassen P; Wei Y; Loeppky C; Shaw SY; Bullard J; Van Caeseele P; Stein DR
    BMC Public Health; 2023 Dec; 23(1):2420. PubMed ID: 38053033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can judgments according to case fatality rate be correct all the time during epidemics? Estimated cases based on CFR in different scenarios and some lessons from early case fatality rate of coronavirus disease 2019 in Iran.
    Moradi G; Piroozi B; Mohamadi-Bolbanabad A; Safari H; Shokri A; Rahimi R
    Med J Islam Repub Iran; 2020; 34():26. PubMed ID: 32551315
    [No Abstract]   [Full Text] [Related]  

  • 18. State of provincial regulations and guidelines to promote low impact development (LID) alternatives across Canada: Content analysis and comparative assessment.
    Ishaq S; Hewage K; Farooq S; Sadiq R
    J Environ Manage; 2019 Apr; 235():389-402. PubMed ID: 30708276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographic variation in bone mineral density and prevalent fractures in the Canadian longitudinal study on aging.
    Hassanabadi N; Berger C; Papaioannou A; Cheung AM; Rahme E; Leslie WD; Goltzman D; Morin SN
    Osteoporos Int; 2024 Apr; 35(4):599-611. PubMed ID: 38040857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying gaps in COVID-19 health equity data reporting in Canada using a scorecard approach.
    Blair A; Warsame K; Naik H; Byrne W; Parnia A; Siddiqi A
    Can J Public Health; 2021 Jun; 112(3):352-362. PubMed ID: 33742310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.